OECD Home › Health › Biotechnology policies › Latest Documents
This report is a summary of exchange of ideas held during the Consultation. Specialists exchanged ideas on the desirability of and possible approaches to xenotransplantation-associated infectious disease surveillance, both at country level and internationally.
The following are the key activities under the Working Party on Biotechnology (WPB).
This document reflects recent efforts made by the OECD to obtain an accurate assessment of the current state of biotechnology statistics in OECD member and observer countries.
Biological Resource Centres (BRCs) are considered to be one of the key elements for sustainable international scientific infrastructure, which is necessary to underpin successful delivery of the benefits of biotechnology.
Water shortage and contamination are cause for increasing concern in many countries. Every year about 13 million people die from waterborne infections; of these, 2 million are children. The majority of deaths occur in developing countries. Howeve...
This summary report discusses some questions raised on : what is a xenogeneic infectious disease event, and what are some of the problems associated with the development of a standardised case definition as well as practical framework for international surveillance.
Regulatory Developments in Xenotransplantation in Hungary.
Regulatory Developments in Xenotransplantation in Germany.
Regulatory Developments in Xenotransplantation in France.